This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endometroid carcinoma of ovary
C3_OVARY_ENDOMETROID
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
214 |
4. Check minimum number of eventsNone |
214 |
5. Include endpointsNone |
214 |
6. Filter based on genotype QC (FinnGen only) |
208 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Endometroid carcinoma of ovary
based on the number of shared cases.
Similar with more cases:
- Endometroid carcinoma of ovary, including Hilmo
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 208 | 208 | - |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | - |
| Median age at first event (years) | 57.83 | 57.83 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 214
- Matched controls
- 2140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
309.9
214
*
H02AB02
ATC
dexamethasone; systemic
176.4
229.2
115
14
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
219.3
171
*
A04AA01
ATC
ondansetron; systemic, rectal
73.6
150.4
85
19
128
Kela drug reimbursment
Cancers of female genital organs
+∞
137.9
117
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
57.9
131.5
78
21
WX302
NOMESCO Finland
Thoracal epidural anesthesy
51.2
118.4
72
21
A03FA01
ATC
metoclopramide; systemic, rectal
18.2
107.3
141
205
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
105.1
92
*
JEA00
NOMESCO Finland
Appendectomy
22.6
88.0
73
48
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
17.0
77.8
76
67
JN4BD
NOMESCO Finland
Extensive body CT
22.5
77.7
63
39
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
28.1
69.6
50
23
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
67.3
61
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
67.3
61
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
60.3
55
*
B01AB10
ATC
tinzaparin; parenteral
10.5
55.2
76
107
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
16.4
51.1
47
36
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
50.0
46
*
JAL30
NOMESCO Finland
Omentectomy
133.1
49.3
51
5
JN4AD
NOMESCO Finland
Body CT examination
12.2
44.8
50
52
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
11.9
37.8
42
43
L03AA13
ATC
pegfilgrastim; parenteral
406.6
35.0
34
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
377.5
32.8
32
*
A04AA02
ATC
granisetron; systemic, transdermal
349.0
30.6
30
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
12.8
30.0
31
28
L02BG04
ATC
letrozole; oral
77.5
29.9
33
5
Z31.5
ICD-10 Finland
Genetic counselling
11.6
29.0
32
32
TPH07
NOMESCO Finland
Cathetrisation of artery
6.4
28.9
58
118
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
28.8
27
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
28.8
27
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
26.6
25
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.4
26.1
64
156
L03AA02
ATC
filgrastim; parenteral
281.5
25.2
25
*
LCD00
NOMESCO Finland
Hysterectomy
7.3
25.1
41
67
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
24.4
23
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
24.4
23
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
268.8
24.2
24
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
23.4
22
*
A04AA03
ATC
tropisetron; systemic
+∞
22.3
21
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.0
21.6
57
146
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
21.2
20
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
231.6
21.0
21
*
HA1AA
NOMESCO Finland
X-ray mammography
7.7
20.6
31
46
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.7
20.1
116
517
B01AB05
ATC
enoxaparin; parenteral
3.7
19.8
110
478
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.7
18.7
52
138
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
18.0
17
*
130
Kela drug reimbursment
Malignant tumour
+∞
18.0
17
*
WX402
NOMESCO Finland
General anaesthesia
4.0
17.9
64
205
JAL00
NOMESCO Finland
Biopsy of peritoneum
69.1
17.0
19
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
16.9
16
*
115
Kela drug reimbursment
Breast cancer
+∞
16.9
16
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
16.9
16
*
Z51.5
ICD-10 Finland
Palliative care
13.2
16.6
29
25
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.4
16.5
49
136
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.5
16.4
46
122
WZC00
NOMESCO Finland
Treatment plan or consultation
3.3
16.2
93
402
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
15.8
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
172.1
15.7
16
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
86.2
14.8
16
*
L02BA01
ATC
tamoxifen; oral
+∞
14.8
14
*
C567, ,
ICD-10 Finland
+∞
14.8
14
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.0
14.4
23
36
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
57.3
14.0
16
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
13.4
14.0
24
20
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
13.7
13
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
13.7
13
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
149.1
13.6
14
*
JAH00
NOMESCO Finland
Laparotomy
12.1
12.9
23
21
JAH01
NOMESCO Finland
Laparoscopy
6.5
12.9
22
37
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
12.9
64
249
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
12.6
12
*
X77
ICPC
Malignant neopl genital female other
+∞
12.6
12
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
12.6
12
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
12.6
12
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
12.6
12
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
137.7
12.6
13
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
11.6
11
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
11.6
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.6
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
126.5
11.5
12
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
26.7
11.3
15
6
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
29.8
10.9
14
5
L02AB02
ATC
medroxyprogesterone; systemic
29.8
10.9
14
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
63.2
10.7
12
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
5.6
10.5
21
41
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
5.6
10.5
21
41
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
10.5
10
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
10.5
10
*
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
42.2
10.1
12
*
N02AA05
ATC
oxycodone; systemic
3.0
10.0
53
211
ZX120
NOMESCO Finland
Intravenous
4.6
9.9
25
60
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
16.0
9.7
15
10
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
22.9
9.5
13
6
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
9.4
9
*
ZXC40
NOMESCO Finland
Use of ultrasound
+∞
9.4
9
*
WW500
NOMESCO Finland
Blood transfusion
10.2
9.0
17
18
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.3
8.9
24
61
N80.1
ICD-10 Finland
Endometriosis of ovary
7.6
8.5
19
27
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
8.4
8
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
15.3
8.3
13
9
R18
ICD-10 Finland
Ascites
15.3
8.3
13
9
XX3DW
NOMESCO Finland
Time consuming IT work
4.3
8.3
22
55
121
Kela drug reimbursment
Severe hypofunction of sexual glands
7.5
8.0
18
26
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
15.8
7.8
12
8
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
26.1
7.6
10
*
K56.7
ICD-10 Finland
Ileus, unspecified
14.0
7.5
12
9
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
7.3
7
*
8102
FHL
Second look"" surgery for a malignant tumor
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
10.6
7.1
13
13
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.8
7.1
22
62
HAB40
NOMESCO Finland
Wedge excision of mammary gland
17.4
6.8
10
6
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
6.8
33
124
D01
ICPC
Abdominal pain/cramps general
2.8
6.7
38
155
B01AB04
ATC
dalteparin; parenteral
4.1
6.7
19
50
N02AX02
ATC
tramadol; systemic, rectal
2.1
6.6
111
725
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.8
6.5
14
19
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
71.9
6.5
7
*
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
71.9
6.5
7
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.7
6.4
12
13
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
JFF10
NOMESCO Finland
Loop enterostomy
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
81
92
13.56
70.12
2.7
1.5
3.15
2.63
ug/l
0.51
62
69
28
42
7.52
18.34
2.8
1.9
32.27
15.86
u/ml
0.94
22
36
58
183
3.98
16.41
11.7
5.0
0.65
1.87
mmol/l
1.49
51
150
86
369
3.22
14.95
2.5
1.8
—
—
—
0
0
136
762
3.15
14.73
5.5
3.3
34.25
35.81
g/l
2.52
131
696
134
775
2.95
13.16
3.0
2.1
—
—
—
0
0
150
933
3.03
12.68
15.0
6.3
3.69
4.16
e9/l
2.38
127
803
141
866
2.84
11.89
8.5
3.2
9.09
10.62
umol/l
2.67
133
805
12
8
15.79
7.81
1.0
1.4
—
—
—
0
0
27
84
3.53
7.54
20.2
5.6
95.41
93.95
%
1.87
27
84
27
86
3.45
7.28
20.2
5.4
0.78
0.72
%
0.27
27
86
27
86
3.45
7.28
19.6
5.4
1.20
1.43
%
1.03
27
86
119
808
2.06
6.29
14.2
13.6
1.24
1.26
inr
0.08
29
234
12
14
9.00
6.14
1.0
2.4
3.76
266.74
u/ml
0.47
12
14
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
34
5.34
6.02
4.5
2.6
0.29
0.41
u/ml
—
7
23
67
381
2.10
5.60
2.0
1.6
1.38
0.94
mg/l
1.10
58
295
168
1340
2.18
5.26
9.4
5.1
81.90
75.59
u/l
1.51
154
1214
39
184
2.37
5.09
17.1
4.0
104.00
104.21
mmol/l
0.09
39
184
9
9
10.37
5.07
2.6
2.6
2054.82
35.59
u/ml
—
9
9
116
826
1.88
4.91
7.9
4.2
1.18
1.22
mmol/l
5.71
110
736
147
1739
0.51
4.77
6.1
6.1
39.80
40.01
mmol/mol
0.10
128
1606
161
1844
0.49
4.56
4.9
4.8
5.83
5.93
mmol/l
0.51
145
1677
127
948
1.84
4.46
4.7
4.0
0.00
0.02
estimate
0.50
16
151
125
937
1.80
4.25
7.2
5.3
0.00
0.00
estimate
-0.00
16
146
122
911
1.79
4.17
8.1
4.9
1.18
1.23
mmol/l
6.75
112
795
26
119
2.35
3.62
1.4
1.5
—
—
—
0
0
19
78
2.58
3.32
16.2
4.4
24.34
25.49
mmol/l
0.89
19
78
169
1874
0.53
3.23
5.1
5.3
2.79
2.81
mmol/l
0.07
150
1711
24
113
2.27
3.14
5.5
4.0
8.16
9.76
mmol/l
0.65
24
102
6
8
7.67
3.07
1.2
1.5
—
—
—
0
0
158
1780
0.57
3.05
5.0
5.4
1.71
2.58
mu/l
0.71
141
1633
14
52
2.81
2.95
10.1
4.3
3.64
3.82
mmol/l
0.71
14
52
165
1834
0.56
2.94
4.6
4.7
4.85
4.83
mmol/l
0.13
148
1683
8
19
4.33
2.70
1.4
1.2
—
—
—
0
0
29
160
1.94
2.55
1.7
2.1
26.41
29.17
u/l
0.43
22
126
8
21
3.91
2.49
1.0
1.4
—
—
—
0
0
8
22
3.74
2.39
1.4
1.2
—
—
—
0
0
41
258
1.73
2.38
2.6
3.0
2.97
5.25
e6/l
0.82
16
122
165
1816
0.60
2.38
4.4
4.7
1.63
1.61
mmol/l
0.25
145
1663
7
17
4.22
2.38
1.4
1.2
—
—
—
0
0
19
93
2.14
2.29
1.8
1.5
—
—
—
0
0
14
60
2.43
2.27
10.1
4.0
1.57
1.29
mmol/l
0.36
14
60
40
594
0.60
2.25
2.1
2.0
113.62
112.50
u/l
0.01
34
561
81
611
1.52
2.25
3.0
3.0
—
—
—
0
0
54
374
1.59
2.18
1.4
1.3
—
—
—
0
0
44
290
1.65
2.16
2.5
2.6
1.57
1.86
e6/l
0.14
17
154
25
141
1.88
2.07
2.5
3.7
225.28
236.38
u/l
0.27
25
130
12
253
0.44
2.07
4.1
4.8
29.60
33.92
%
—
5
160
74
562
1.48
1.95
3.0
2.0
103.24
55.27
u/l
0.54
67
504
63
464
1.51
1.92
2.4
3.0
0.37
0.56
e6/l
0.65
39
348
113
935
1.44
1.89
5.2
3.9
0.00
0.01
estimate
0.50
19
162
81
636
1.44
1.77
4.1
2.1
2.35
2.37
mmol/l
0.50
73
528
137
1541
0.69
1.77
4.1
4.4
14.78
14.88
pmol/l
0.17
118
1409
5
13
3.91
1.72
1.0
1.2
—
—
—
0
0
26
159
1.72
1.68
2.9
2.5
2.11
2.77
mmol/l
0.38
20
135
5
15
3.39
1.53
1.4
1.1
—
—
—
0
0
6
21
2.91
1.51
1.0
1.2
—
—
—
0
0
7
28
2.55
1.46
1.3
1.3
—
—
—
0
0
162
1747
0.70
1.37
3.9
4.2
1.29
1.26
mmol/l
0.34
140
1579
29
195
1.56
1.33
2.0
1.7
—
—
—
0
0
50
377
1.43
1.33
4.5
4.0
17.54
98.83
ng/l
1.64
41
291
8
160
0.48
1.30
3.3
3.1
103.25
74.04
ng/l
—
8
140
29
196
1.55
1.30
1.9
1.7
—
—
—
0
0
189
1774
1.56
1.28
21.3
12.2
35.93
19.85
mg/l
6.47
168
1350
15
86
1.80
1.22
2.7
2.1
0.68
0.65
%
0.17
15
86
8
39
2.09
1.16
1.5
1.7
—
—
—
0
0
15
88
1.76
1.14
2.7
2.1
1.13
1.10
%
0.07
15
88
11
59
1.91
1.09
1.6
1.5
—
—
—
0
0
23
154
1.55
1.09
2.6
3.2
—
—
—
0
0
7
32
2.23
1.09
1.0
1.1
—
—
—
0
0
70
834
0.76
1.07
2.4
2.3
83.17
80.65
nmol/l
0.25
63
729
7
34
2.09
1.04
1.0
1.3
—
—
—
0
0
7
34
2.09
1.04
1.0
1.3
—
—
—
0
0
36
270
1.40
0.99
1.9
1.7
—
—
—
0
0
51
626
0.76
0.95
3.6
3.5
12.31
3.98
mg/mmol
1.15
30
353
191
1979
0.68
0.91
35.5
18.3
4.16
4.40
e12/l
9.36
183
1912
191
1979
0.68
0.91
37.1
18.2
36.67
39.46
%
10.06
178
1812
191
1978
0.68
0.89
35.5
18.3
265.04
261.18
e9/l
0.36
185
1919
6
30
2.03
0.87
1.3
1.2
—
—
—
0
0
6
111
0.53
0.86
1.0
1.5
—
—
—
0
0
6
31
1.96
0.85
1.2
1.4
—
—
—
0
0
6
34
1.79
0.77
1.5
1.5
—
—
—
0
0
7
41
1.73
0.70
3.6
2.5
—
—
—
0
0
5
27
1.87
0.69
1.2
1.0
—
—
—
0
0
5
27
1.87
0.69
1.0
1.4
—
—
—
0
0
14
95
1.51
0.66
1.4
1.5
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
53
452
1.23
0.60
2.4
2.2
3.20
3.19
mg/l
0.01
43
372
34
413
0.79
0.58
1.1
1.3
0.56
2.34
u/ml
—
8
100
29
357
0.78
0.55
1.3
1.3
50.79
12.47
u/ml
—
7
131
94
1026
0.85
0.53
2.9
2.8
—
—
—
0
0
75
831
0.85
0.51
2.4
2.0
78.30
100.68
pmol/l
2.74
34
375
7
46
1.54
0.49
1.4
1.4
—
—
—
0
0
44
377
1.21
0.48
3.1
2.2
2.48
2.45
mmol/l
0.76
38
321
15
114
1.34
0.42
4.0
2.7
4.39
4.46
pmol/l
0.15
15
98
18
141
1.30
0.42
2.6
2.2
54.78
64.60
ml/min/173m2
—
9
53
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
94.40
—
0
5
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
9
68
1.34
0.38
1.3
1.2
—
—
—
0
0
132
1384
0.88
0.37
3.9
4.5
16.80
12.64
mm/h
1.71
118
1253
6
42
1.44
0.36
1.0
1.1
—
—
—
0
0
34
381
0.87
0.26
1.5
1.7
1281.92
1176.94
nmol/l
0.27
26
278
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
105.47
—
0
10
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
77
812
0.92
0.21
3.3
2.6
101.18
90.59
ug/l
0.22
71
739
172
1684
1.11
0.20
21.8
11.1
75.40
76.80
ml/min/173m2
0.37
146
1329
0
14
0.00
0.20
0.0
1.7
—
26.80
—
0
5
10
122
0.81
0.19
1.0
1.7
—
—
—
0
0
25
279
0.88
0.19
1.5
1.5
—
—
—
0
0
45
420
1.09
0.16
2.1
2.1
12012.92
6162.66
umol/l
0.20
38
354
6
76
0.78
0.16
4.0
3.8
3.23
2.10
mmol/l
—
6
57
38
408
0.92
0.15
1.5
1.8
1750.12
481.61
pmol/l
0.45
26
321
76
729
1.07
0.14
4.5
4.0
—
—
—
0
0
10
85
1.19
0.12
1.0
1.1
—
—
—
0
0
71
687
1.05
0.09
4.7
3.7
29.67
71.12
ng/l
0.39
51
487
5
48
1.04
0.09
5.0
1.2
—
0.99
—
0
7
114
1118
1.04
0.08
4.1
2.8
48.14
41.10
u/l
0.51
100
1017
11
99
1.12
0.06
1.1
1.4
—
—
—
0
0
51
522
0.97
0.04
1.9
1.6
1.48
1.34
mmol/l
0.62
43
439
189
1899
0.96
0.03
29.0
14.1
70.56
70.62
umol/l
0.02
189
1899
56
570
0.98
0.02
3.4
2.6
2700.47
1127.15
ng/l
0.67
49
471
35
359
0.97
0.02
1.3
1.3
19.89
44.38
iu/ml
—
9
124
12
126
0.95
0.00
2.7
1.7
—
—
—
0
0
25
256
0.97
0.00
11.0
6.9
—
—
—
0
0
49
489
1.00
0.00
5.0
4.5
0.06
0.00
estimate
0.48
17
152
49
491
1.00
0.00
1.8
1.5
23.96
22.35
nmol/l
0.31
42
416
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
1.8
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
2249.00
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1.88
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
6
66
0.91
-0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
55
0.91
-0.00
1.8
1.5
—
—
—
0
0
5
51
0.98
-0.00
2.0
1.3
148.00
198.33
ug/l
—
5
45
5
51
0.98
-0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
10.01
—
0
7
0
7
0.00
-0.00
0.0
2.6
—
501.43
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
6
65
0.92
-0.00
1.5
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
1.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_ENDOMETROID – Endometroid carcinoma of ovary
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).